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MAG3 Renogram Deconvolution in Kidney
Transplantation: Utility of the Measurement
of Initial Tracer Uptake
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The study of renal retention function by deconvolution analysis of
renographic curves is useful to calculate quantitative parameters in
renal studies. The aim of the work is to evaluate the usefulness of
99mTc-MAG3 renogram deconvolution in renal function monitoring
of kidney graft recipients. Methods: Forty-three kidney grafts and
112 renograms were studied: 41 were diagnosed as functioning
graft, 35 as acute tubular necrosis, 24 as acute rejection, 8 as
obstruction and 4 as cyclosporin toxicity. The parameters calcu
lated were mean transit time (MTT), time at 20% of renal retention
function (T20) and initial uptake (IU). Results: MTT and T20 were
significantly longer in obstructives than in functioning grafts (p <
0.001). Initial uptake was significantly lower in acute tubular necrosis
(ATN) and acute rejection (p < 0.001) and in obstructives (p < 0.05)
than in functioning grafts. The joint evaluation of MTT and IU allowed
to diagnose cases with graft function severely impaired.
Conclusion: Initial uptake is useful in evaluating post-transplanta
tion complications and in combination with MTT and T20 reflects
renal dysfunction severity.
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"ynamic renal scintigraphy is routinely applied in most
nuclear medicine departments to study renal transplants ( /). The
technique is accurate for the functional evaluation of kidney
function and is a useful tool for clinicians in the postoperative
follow-up of transplanted patients (2,3). Since its introduction
in 1987, the use of mercapto-acetyl-triglycine (MAG-3) labeled
with WmTc has increased and progressively replaced mI-OIH
and 99n'Tc-DTPA as tracer for renal functional studies.
Several different parameters are used to follow the kidney's
progress. This fact suggests that there is not one that is ideal.
Nevertheless, it can be agreed that to determine the intrarcnal
kinetics and to calculate quantitative parameters, the study of
the renal retention function (RRF) is useful. The RRF is
calculated by deconvolution analysis of the renographic curves
(4). There is little experience in deconvolution in renal trans
planted patients (5-7) and even less with 99mTc-MAG3 (fi).
In 1992, we developed a deconvolution method for MAG3
renography, for which initial results in normal volunteers and
functioning kidney grafts were promising (9). The aim of this
work was to study the usefulness ofthat deconvolution method
with 99mTc-MAG3 in kidney graft monitoring. We evaluated
the RRF derived parameters: initial uptake (IU) and two transit
times of the tracer: mean transit time (MTT) and time at 20% of
the RRF (T20). We analyzed if they reflect the graft function
accurately and also compared the RRF with the effective renal








FIGURE 1. Graphic representation of MTT, T20 and IU calculation.
plasma flow (ERPF) (measured with 13II-OIH) and with the
serum creatinine values.
MATERIALS AND METHODS
We studied 43 kidney graft recipients (22 men, 21 women; range
15-63 yr; mean age 41 yr). All patients were referred for renogram
studies and underwent transplantation between 24 hr and 6 mo
before the study began. One hundred-twelve renogram studies were
obtained and analyzed.
Patients were categorized into five groups including:
1. Functioning graft (FG) (n = 41). Patients with adequate
diuresis, without clinical signs of rejection on the day of
study or the following week and serum creatinine <200
mmol/liter.
2. Acute tubular necrosis (ATN) (n = 35) was diagnosed on the
clinical and biochemical requirement of hemodialysis, ab
sence of rejection signs and clinical and renographic im
provement after only supportive therapy. In some cases, graft
biopsy was also obtained.
3. Acute rejection (AR) (n = 24). Diagnosis was always based
on histolÃ³gica! data, and only the exams performed before
rejection treatments began were included.
4. Obstruction (OBS) (n = 8). Ultrasonography demonstrated
the urinary tract dilatation, and subsequently obstruction was
the clinical diagnosis.
5. Cyclosporin toxicity (CTX) (n = 4) was diagnosed by
exclusion of other diagnoses. The presence of high serum
levels of CyA as well as renal function recovery and clinical
improvement after cyclosporin withdrawal were the main
criteria (10).
The diagnosis was established by the nephrologist without
knowledge of deconvolution results.
A basal study performed within 24-72 hr of kidney transplan
tation was initially obtained and follow-up examinations were






+SD 215*54 3iaÂ±i93 312*174 393*91Â«2rsÂ±io8Range
100-375 0-686 0-652 225-480178-43 *
p < 0.001 vs. functioning graft
FIGURE 2. Mean Â±1 s.d. and range of MTT.
patients, a study was made 3 mo post-transplantation at the time of
a control kidney graft biopsy.
Renograms were obtained in anterior view, using a large field of
view gamma camera fitted with a 140 KeV, LEAP collimator
positioned over the patient in the supine position. A bolus of
222-259 MBq 99mTc-MAG3 was injected intravenously into an
antecubital vein. During 24 min, 114 frames were recorded: a first
group at 2.5 sec intervals for 120 sec, followed by a second group
of 66 frames at 20 sec intervals. At the same time, in the
contralateral antecubital vein, 1.85 MBq of '"l-OIH was injected
to calculate the ERPF. The ERPF was measured using the three
blood samples method (7, 17 and 30 min) used routinely in our
institution as previously published (11). Regions of interest (ROIs)
were defined for the whole kidney, abdominal aorta (before aortic
bifurcation) and background (graft mirror in the contralateral iliac
fossa, avoiding vascular and urinary tract structures if present). By
deconvolution analysis of renal output (renogram curve) with renal
input (aortic curve), the renal retention function was obtained. The
deconvolution method used was developed in our department (9).









268Â±105 626Â±521 633*632 820*532* 493Â±413
Range 0-535 0-1429 0-1428 291-1272203-1105*
p < 0.001 vs functioning graft
FIGURE 3. Mean Â±1 s.d. and range of T20.
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t p < 0.05 vs functioning graft
FIGURE4. Mean Â±1 s.d.andrangeof ID.
IU AR B ATN â€¢FG
FIGURE 5. Distributionof IU in FG, ATN and AR. The cutoff value for IU is 1.6.
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From the RRF, the following parameters were calculated: the
MTT, or the average time that the tracer stays in the kidney, was
calculated by dividing the area under the RRF by the first value of
the curve (H0); T20, or the time at 20% of the maximum height of
the RRF (H0); IU, or retention at zero time (Hn), multiplied by 100
(Fig. 1).
Statistical significance of differences between groups was deter
mined by U Mann-Whitney test. The correlation between IU and
ERPF and serum creatinine was calculated by the Pearson Coefi-
cient.
RESULTS
Figures 2, 3 and 4 show mean Â±s.d. of MTT, T20 and IU in
the groups studied.
MTT and T20 were prolonged in all groups in relation to
functioning grafts. Nevertheless, differences were statistically
significant only with obstructed kidneys (p < 0.001). IU was






















FIGURE 7. Clinicalevolutionof a 44-yr-old patient who received a renal graft.
(A) Renograms with ""Tc-MAGS of the four studies performed on this
patient. (B) RRF parameters evolution. The first study was performed within
24 hr of kidney transplantation, reflecting an ATN in the renogram and the
RRF. The second study was performed 7 days later on the following day of
the last hemodialysis session. The third study was performed 9 days
FIGURE 6. Significantcorrelation was found between ERPF and IU (n = 98, posthospital discharge. Renogram and RRF improve remarkably.The fourth
r = 0.73, p < 0.01). study was performed 2 mo later. Renogram and RRF were normal.
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FIGURE 8. Serial studies of a 49-yr-old patient who suffered an ATN and AR mixed. (A) Renograms with ""Tc-MAG3 of the five studies performed on this
patient. (B) RRF parameter evolution. The first study reflects an ATN in the renogram and in the RRF on the first day post-transplantation. In the second study,
7 days later, renogram has not changed, but MTT and T20 have decreased below the normal range. In the third study, 3 days later, renogram continued
without change and RRF parameters became still shorter. A biopsy shows severe ATN and AR, and the patient receives specific treatment the following day.
In the fourth study, 7 days later, the renogram is similar to the previous ones. RRF parameters increased. After 4 days urine production began. In the fifth study,
3 mo later, renogram improves notably, and RRF parameters were within the normal range.
OBS (p < 0.05) than in functioning grafts. There were no
significant differences between ATN and AR. In functioning
grafts, IU was equal or greater than 1.6 in all cases but three. In
these three cases, IU was 1.4, 1.3 and 0.9, respectively. In the
last case, a routine ultrasonographic study disclosed a perirenal
liquid collection.
In ATN and AR patients, IU was lower than 1.7 in all cases
but two. In a case of a very mild acute rejection and a case of
ATN, IU was 2.16 and 1.77, respectively. Figure 5 shows the
distribution of IU in FG, ATN and AR.
Using the cutoff value of 1.7, the sensitivity for the detection
of ATN was 97.1%, the detection of AR was 95.8%. Specificity
was 60.0% and 51.3%, respectively. There was a significant
inverse correlation between serum creatinine and IU (n = 103,
r = -0.78, p < 0.01), that is IU decreases when serum
creatinine increases. The correlation between ERPF and IU is
also significant (n = 98, r = 0.73, p < 0.01), that is ERPF
increases when IU increases (Fig. 6).
In the follow-up of patients, IU and transit time evolution
corresponded with clinical evolution. Figures 7 and 8 show the
results for two patients with different diagnosis and evolution in
whom the conventional renogram does not change significantly
while IU, MTT and T20 do.
DISCUSSION
The results obtained show the strength of the deconvolution
method used in renal transplant. The method is potent enough
and was applied to all the renograms, the mathematical process
failed only in 3 cases, and that was usually due to the severity
renal function impairment.
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Our results are in agreement with previously published values
with different tracers (12-14). MTT and T20 are prolonged in
AR and ATN when compared with functioning grafts, as
expected.
Ill (defined as the first point of the RRF X 100) is, among the
parameters studied, the most sensitive one to changes in
parenchymal function. Mean value in FG was 1.6, and it
significantly decreased in ATN and AR. Only 4 of the 41 FG
cases studied were below the cutoff value of 1.6. Concerning
abnormal groups, only 1 of 21 AR cases and 1 of 35 ATN
studied were greater than 1.60. Obstructed graft and nephrotox-
icity cases showed a wider range reflecting the renal function
impairment of each case. Cyclosporin nephrotoxicity was sus
pected rather early when renal function was not severely
damaged. CyA dosage rapidly decreased in all cases, and the
clinical evolution with recovery of renal function confirmed the
diagnosis. However, because of the small number of cases of
CyA toxicity studied, no conclusion can be drawn. Obstructed
kidneys show a significant decrease of ID, although less
significantly than in AR and ATN. This may be due to varying
degrees of pathologic changes that happen in obstructive
problems.
A large overlap was found both for MTT and T20 between
AR and NTA. The large s.d. found in both groups reflects the
different degree of renal function impairment that can be
observed in clinical practice in these patients. In some patients,
we observed that MTT and T20 can be about the normal range
or slightly below, while the IU significantly decreases. This fact
reflects a more severe impairment of renal function. In these
patients, tracer transit through the kidney is very fast, possibly
because the MAG3 circulates only through the vascular renal
network and neither glomerular filtration nor tubular extraction
occurs significantly. In our experience the combination of an
IU < 1.6 and a MTT < 160 were only seen in patients with very
severe ATN and/or severe AR. In these patients, recovery began
by a prolonged MTT over normal values, that was followed by
IU increase and finally normalization of both MTT and IU.
Figure 8 illustrates this hypothesis. It shows the evolution of a
patient who begins with an ATN with prolonged transit times
and low IU. A few days later, IU maintains while MTT and T20
decrease. This pattern is more dramatic some days later. A graft
biopsy shows severe ATN and AR. In the following days, after
specific treatment for AR, MTT and T20 increase, parallelly IU
increases and finally, in the last control subject, MTT and T20
become normal and IU is about four. It is important to note that
the RRF obtained with this method is faster in reflecting
changes in renal function and is more accurate in showing the
state of graft function than the typical renogram with 99mTc-
MAG3.
Our findings with 99mTc-MAG3 are consistent with other
reports ( 7,14) since MTT is significantly prolonged in the group
of obstructions. Also, in our study, T20 is significantly pro
longed.
Especially interesting is the significant correlation found
between IU and blood creatinine. Though each agent is handled
by the kidney in a different way, it shows the correlation
between renal function and IU and how renal function can be
quantified and standardized by using the IU. In the patient
follow-ups, IU variations seem more useful than creatinine,
especially if it is used in combination with MTT. Because
MAG3 is a tubular tracer, we have looked for the correlation
with ERPF and not with the glomerular filtration rate. The
initial uptake of tracer corresponds with the kidney tubular
function as shows the significant correlation found between
ERPF and IU.
The IU usefulness as follow-up parameter increases too. A
basal study should be obtained within the first 24-48 hr
post-transplantation. Thereafter, posterior IU must be compared
with the basal one. The decrease of the IU suggests renal
function impairment, while its increase, at any moment, sug
gests renal function improvement. Concerning the conventional
renogram, the IU measurement is a parameter that allows
quantification of tubular renal function. It is less subjective than
visual inspection of images or renographic curves and more
accurate than the other parameters studied.
CONCLUSION
The parameter proposed is much more potent and less
modifiable by tracer maladministration than the maximal up
take of tracer calculated in the usual renogram with 99mTc-
MAG3. It can be used to monitor renal function graft evolution
even in patient with ATN. The combined use of IU with MTT
and T20 increases the accuracy of the method and reflects renal
dysfunction severity. Decreased IU and under normal transit
times reflect more severe graft damage than decreased IU and
over normal transit times. Therefore, though a single value can
be significant, it is recommendable to obtain a basal study and
use the initial values of IU, MTT and T20 as reference in
follow-up studies.
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